A Webinar on ISOPP Standards -- Oral Anticancer Therapies and Monoclonal Antibodies

A Webinar on ISOPP Standards--Oral Anticancer Therapies and Monoclonal Antibodies

Thursday, May 11, 2023, 6am to 7am PDT
Presenters:  Lisa Holle and Lynne Nakashima
Moderator:  Himanshu Patel, ISOPP Education Committee Chair

Click here for local time of the webinar for you


The recording is available for viewing by ISOPP members for up to 12 months post event. Non-members are invited to join ISOPP to view the recording.   Members, simply login as a member and visit the Watch a Webinar page.  

Please click below to view the recording: 
View recording

Learning Objectives

1.    Describe the recommended standards for prescription content, dispensing, and monitoring of anticancer therapies
2.    Outline optimal training and education about oral anticancer therapies for patients, caregivers, and staff
3.    Describe the evaluation of potential health hazards of monoclonal antibodies
4.    Outline safe handling and administration standards for monoclonal antibodies

Session Description

This session aims to provide the attendee with an overview of the new standards on oral anticancer therapies and monoclonal antibodies that have been incorporated into the 2022 update of the International Society of Oncology Pharmacy Practitioners (ISOPP) Standards for Safe Handling of Cytotoxics. Oral anticancer therapies include cytotoxic, targeted, and endocrine therapies as well as immunotherapies. These drugs, although administered in outpatient setting, still carry significant risk to the patients and others.  The ISOPP standards describe the processes for ensuring the safety of ordering, dispensing, and monitoring of these therapies. Additionally, training and education both for the healthcare team and patient and caregivers are recommended. 

As compared to cytotoxic drugs, there is limited information available to guide evaluation of the potential health hazards of monoclonal antibodies.  The ISOPP standards provide information and direction on the safe handling and administration of monoclonal antibodies.

Presenter information: 
Lisa M. Holle, PharmD, BCOP, FHOPA, FISOPP

Dr. Holle completed her Bachelor of Science in Pharmacy and post-baccalaureate Doctor of Pharmacy from the University of Wisconsin–Madison. She completed a specialized oncology residency at UT M.D. Anderson Cancer Center, and is a board-certified oncology pharmacist. Dr. Holle has worked as an oncology pharmacist for over 25 years in a variety of settings including private hospitals, academic medical centers, and medical communications. Currently, Dr. Holle is a Clinical Professor at the UConn School of Pharmacy and at the UConn School of Medicine. Her practice site is at the UConn Health Carole and Ray Neag Comprehensive Cancer Center, where she works in a team-based ambulatory care clinic focusing on genitourinary and gastrointestinal cancers and was a co-lead in the developing of their oral anticancer medication program.

Dr. Holle is a Past President of the Hematology Oncology Pharmacy Association (HOPA) and a past Secretariat member and past Treasurer of the International Society of Oncology Pharmacy Practitioners (ISOPP). She is also an active member in many other professional oncology and pharmacy organizations. Dr. Holle’s clinical research program focuses on numeracy and patient decision-making, oncology quality improvement initiatives, medical marijuana, and oral anticancer therapy management. She has authored numerous articles and chapters on oncology and teaching-related topics. 

Lynne Nakashima, BSc(Pharm), RPh, PharmD, FCAPhO, FISOPP
Dr. Lynne Nakashima received her BSc(Pharm) from the University of British Columbia, Canada and her PharmD from the University of North Carolina at Chapel Hill, USA.  She is currently the Senior Director, Provincial Pharmacy at BC Cancer where she is responsible for pharmacy professional practice, the cancer drug formulary and coordinates a team of advanced practice pharmacists and pharmacy technicians.  Lynne is a Fellow of CAPhO and ISOPP and is a member of the ISOPP Engagement and Communications Committee and a member of the JOPP Editorial Board.  In her spare time, Lynne enjoys golfing, reading and collecting sheep.



Promote the Webinar
Print copies of the invitation flyer and share the opportunity by posting them within your workplace.

After you have attended the webinar, a short evaluation will be emailed to you. In addition to completing the evaluation, let us know if you have any further comments or suggestions by emailing membership@isopp.org.

Question and Answer (Q&A)
Please click here for Q&A sent after the webinar: Q&A

Terms of Use
Please read ISOPP’s Terms of Use.

If you are interested in presenting a webinar, please email education@isopp.org. We welcome everyone's participation in Educational Webinars.